Back to search

PES-EU-Prosjektetablererstøtte EU (bedrift)

A Late-Stage Clinical Development Programme of SER101 (an Oral 5-HT4 Receptor Antagonist) as a New Chemical Entity in the Treatment of Conge

Awarded: NOK 0.21 mill.

Funding scheme:

PES-EU-Prosjektetablererstøtte EU (bedrift)